AZN250110C67000
- 0.01
- 0.000.00%
AstraZeneca Newsroom
Allurion (ALUR.US) stock price surged violently; its new weight loss therapy can maintain muscle mass.
On Thursday, Allurion's stock price soared 80% in after-hours trading, following reports that the company plans to conduct clinical research combining its gastric balloon weight loss product with GLP-1 drugs.
Allurion Stock Soars 70% on Weight-loss Therapy Update
AstraZeneca to Invest C$820 Million to Move to Larger Toronto Office
Astrazeneca Announces A $570M Investment In Canada, Creating More Than 700 High-Skilled Jobs
Why Is AstraZeneca PLC (AZN) Among the Best Large-Cap Value Stocks to Buy in 2025?
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Investors Who Lost Money on AstraZeneca PLC (AZN) Should Contact Levi & Korsinsky About Pending...
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
AstraZeneca Gains NICE Nod for Lung Cancer Drugs Tagrisso and Imfinzi
AstraZeneca Put Volume Heavy and Directionally Bearish
Monopar Therapeutics Gains 'Buy' Rating Amid Promising Licensing Deal With AstraZeneca and Strong Growth Prospects
Leerink Partners Maintains AstraZeneca(AZN.US) With Buy Rating, Maintains Target Price $87
AstraZeneca's Strategic Positioning and Datroway Approval Drive Buy Rating Amidst Evolving Breast Cancer Treatment Landscape
Takeda-backed Ascentage Pharma Sets Terms for $170M IPO
Analysts' Opinions Are Mixed on These Healthcare Stocks: AstraZeneca (GB:AZN), CSL (OtherCMXHF) and UCB SA (GB:0NZT)
AstraZeneca (AZN) Gets a Buy From Goldman Sachs
Reported Friday, FDA Approves Daiichi Sankyo And AstraZeneca's DATROWAY AS A New Treatment Option For HR Positive, HER2 Negative Breast Cancer In The U.S.
Trinasolar Powers AstraZeneca's Sustainability Vision With Cutting-Edge Solar Carpark Rooftop Install
BofA Securities Maintains AstraZeneca(AZN.US) With Buy Rating, Announces Target Price $91.7
Bank of America Securities Remains a Buy on AstraZeneca (AZN)